Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis
Open Access
- 21 November 2017
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 70 (9) , 1373-1384
Abstract
Objective: Raynaud's phenomenon (RP) is the most common manifestation of systemic sclerosis (SSc). RP is an episodic phenomenon, not easily assessed in the clinic, leading to reliance on self‐report. A thorough understanding of the patient experience of SSc‐RP is essential to ensuring that patient‐reported outcome (PRO) instruments capture domains important to the target patient population. We report the findings of an international qualitative research study investigating the patient experience of SSc‐RP.Methods: Focus groups of SSc patients were conducted across 3 scleroderma centers in the US and UK, using a topic guide and a priori purposive sampling framework devised by qualitative researchers, SSc patients, and SSc experts. Focus groups were audio recorded, transcribed, anonymized, and analyzed using inductive thematic analysis. Focus groups were conducted until thematic saturation was achieved.Results: Forty SSc patients participated in 6 focus groups conducted in Bath (UK), New Orleans (Louisiana), and Pittsburgh (Pennsylvania). Seven major themes were identified that encapsulate the patient experience of SSc‐RP: physical symptoms, emotional impact, triggers and exacerbating factors, constant vigilance and self‐management, impact on daily life, uncertainty, and adaptation. The interrelationship of the 7 constituent themes can be arranged within a conceptual map of SSc‐RP.Conclusion: We have explored the patient experience of SSc‐RP in a diverse and representative SSc cohort and identified a complex interplay of experiences that result in significant impact. Work to develop a novel PRO instrument for assessing the severity and impact of SSc‐RP, comprising domains/items grounded in the patient experiences of SSc‐RP identified in this study, is underway.Keywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K24 AR 063120)
This publication has 41 references indexed in Scilit:
- Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National SurveyRheumatology, 2010
- Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group databaseAnnals of the Rheumatic Diseases, 2007
- Successful treatment of patients with severe secondary Raynaud's phenomenon with the endothelin receptor antagonist bosentanRheumatology, 2006
- How Many Interviews Are Enough?Field Methods, 2006
- Using thematic analysis in psychologyQualitative Research in Psychology, 2006
- Prevalence of Raynaud's phenomenon in a healthy Greek populationAnnals of the Rheumatic Diseases, 2000
- Losartan therapy for Raynaud's phenomenon and scleroderma: Clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trialArthritis & Rheumatism, 1999
- Ketanserin: An Effective Treatment Regimen for Digital Ischaemia in Systemic SclerosisScandinavian Journal of Rheumatology, 1989
- Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis.Annals of the Rheumatic Diseases, 1988
- Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2)British Journal of Dermatology, 1982